{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:48:51Z","timestamp":1776988131142,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ijtb.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T08:33:04Z","timestamp":1462091584000},"page":"13-18","source":"Crossref","is-referenced-by-count":11,"title":["Vaccines against tuberculosis: A review"],"prefix":"10.1016","volume":"63","author":[{"given":"Salil","family":"Bhargava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyadeo","family":"Choubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyendra","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2016.02.005_bib0210","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.ijtb.2016.02.005_bib0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tube.2004.09.015","article-title":"Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials","volume":"85","author":"Helen McShane","year":"2005","journal-title":"Tuberc Edinb Scotl"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(91)90017-M","article-title":"The global tuberculosis situation and the new control strategy of the World Health Organization","volume":"72","author":"Kochi","year":"1991","journal-title":"Tubercle"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0225","series-title":"Stop TB Partnership. The Global Plan to Stop TB","year":"2006"},{"issue":"5","key":"10.1016\/j.ijtb.2016.02.005_bib0230","first-page":"200","article-title":"Tuberculosis in the HIV-positive patient","volume":"56","author":"Corbett","year":"1996","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0235","series-title":"Issues Relating to the Use of BCG in Immunisation Programmes","author":"Fine","year":"1999"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0240","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"9493","key":"10.1016\/j.ijtb.2016.02.005_bib0245","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"5419","key":"10.1016\/j.ijtb.2016.02.005_bib0250","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ijtb.2016.02.005_bib0255","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a metaanalysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"11\u201312","key":"10.1016\/j.ijtb.2016.02.005_bib0260","first-page":"156","article-title":"Vaccine strategies against tuberculosis","volume":"139","author":"McShane","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0265","doi-asserted-by":"crossref","unstructured":"McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Adrian VS. Boosting BCG with MVA85A: the First Candidate Subunit Vaccine for Tuberculosis in Clinical Trials Hill Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK. http:\/\/www.idpublications.com\/journals\/PDFs\/TUBE\/TUBE_MostCited_1.pdf [accessed 17.09.04].","DOI":"10.1016\/j.tube.2004.09.015"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0270","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0264-410X(90)90002-4","article-title":"Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis","volume":"8","author":"Stanford","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0275","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0035-9203(00)90088-9","article-title":"Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991\u201397","volume":"94","author":"Mayo","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1579","key":"10.1016\/j.ijtb.2016.02.005_bib0280","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1098\/rstb.2011.0097","article-title":"Tuberculosis vaccines: beyond bacille Calmette\u2013Gu\u00e9rin","volume":"366","author":"McShane","year":"2011","journal-title":"Philos Trans R Soc Lond B: Biol Sci"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0285","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0290","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.vaccine.2009.12.083","article-title":"The second Geneva consensus: recommendations for novel live TB vaccines","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0295","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.vaccine.2005.03.001","article-title":"New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development","volume":"23","author":"Kamath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0300","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus Calmette\u2013Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0305","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette\u2013Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0310","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette\u2013Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0315","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0320","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/hv.8570","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: tolerability and immunogenicity in humans","volume":"5","author":"Von Eschen","year":"2009","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0325","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/CVI.00133-10","article-title":"Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F\/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults","volume":"17","author":"Leroux-Roels","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0330","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette\u2013Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0335","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0340","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0345","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferongamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0350","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"Dietrich","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0355","doi-asserted-by":"crossref","unstructured":"Tuberculosis vaccines: beyond bacille Calmette\u2013Gu\u00e9rin | Philos Trans R Soc B: Biol Sci. [cited 2014 Dec 10]. Available from: http:\/\/rstb.royalsocietypublishing.org\/content\/366\/1579\/2782.","DOI":"10.1098\/rstb.2011.0097"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0360","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3201\/eid1210.060078","article-title":"Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa","volume":"12","author":"Xiang","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0365","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00002030-200405210-00019","article-title":"Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector","volume":"18","author":"Kostense","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0370","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0375","doi-asserted-by":"crossref","first-page":"e3790","DOI":"10.1371\/journal.pone.0003790","article-title":"rBCG induces strong antigen specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector","volume":"3","author":"Magalhaes","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0380","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0385","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's Transl)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol B"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0390","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0395","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette\u2013Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0400","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijtb.2016.02.005_bib0405","unstructured":"Stop TB Working Group MVA85A Trial Q&A."},{"key":"10.1016\/j.ijtb.2016.02.005_bib0410","article-title":"What's new in tuberculosis vaccines?","author":"Ginsberg","year":"2002","journal-title":"Bull World Health Organ"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570716300452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570716300452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T06:25:25Z","timestamp":1567837525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570716300452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0019570716300452"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2016.02.005","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}